Clinical case of treating hypercholesterolemia associated with impaired fasting glycemia

Dyslipidemia and diabetes mellitus are among the leading risk factors for atherosclerosis. Statins act as first-line drugs in the correction of dyslipidemia. However, most statins can increase the risk of developing and worsen the course of type 2 diabetes. Pitavastatin is the only statin that can increase the level of adiponectin and thus have a beneficial effect on glucose metabolism. The author gives an example of the use of pitavastatin in a patient with insulin resistance and a high risk of developing type 2 diabetes mellitus.